P718: EPIGENOME PROFILING REVEALS ABERRANT DNA METHYLATION SIGNATURE IN GATA2 DEFICIENCY

• Oskar Marin-Bejar,
• Damia Romero-Moya,
• Javier Rodriguez-Ubreva,
• Maximiliano Distefano,
• Francesca Lessi,
• Paolo Aretini,
• Alessandro Liquori,
• Julio Castaño,
• Emilia Kozyra,
• Lili Kotmayer,
• Clara Bueno,
• José Cervera,
• José Carlos Rodriguez-Gallego,
• Josep F Nomdedeu,
• Laura Murillo-Sanjuán,
• Cristina Díaz de Heredia,
• Antonio Pérez-Martinez,
• Félix López-Cardenas,
• Carolina Martínez-Laperche,
• Nieves Dorado-Herrero,
• Francisco M Marco,
• Felipe Prósper,
• Pablo Menendez,
• David Valcárcel,
• Esteban Ballestar,
• Csaba Bödör,
• Anna Bigas,
• Albert Catalá,
• Marcin W Wlodarski,
• Alessandra Giorgetti

Affiliations

Oskar Marin-Bejar

1 Regenerative Medicine Program, Bellvitge Institute for Biomedical Research (IDIBELL) and Program for Clinical Translation of Regenerative Medicine in Catalonia (P-CMRC), Barcelona, Spain

Damia Romero-Moya

1 Regenerative Medicine Program, Bellvitge Institute for Biomedical Research (IDIBELL) and Program for Clinical Translation of Regenerative Medicine in Catalonia (P-CMRC), Barcelona, Spain

Javier Rodriguez-Ubreva

2 Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), Barcelona, Spain

Maximiliano Distefano

3 Department of Hematology and Oncology, Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Déu, Barcelona, Spain

Francesca Lessi

4 Fondazione Pisana Per la Scienza ONLUS (FPS), San Giuliano Terme, Italy

Paolo Aretini

4 Fondazione Pisana Per la Scienza ONLUS (FPS), San Giuliano Terme, Italy

Alessandro Liquori

5 Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain

Julio Castaño

7 Advanced Cell Therapy Services. Banc de Sang i Teixits de Catalunya, Barcelona, Spain

Emilia Kozyra

8 Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine; Faculty of Biology, University of Freiburg, Freiburg, Germany

Lili Kotmayer

9 HCEMM-SE Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary

Clara Bueno

10 Josep Carreras Leukaemia Research Institute. Department of Biomedicine. School of Medicine, University of Barcelona, Barcelona, Spain

José Cervera

5 Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain

José Carlos Rodriguez-Gallego

12 Department of Immunology, University Hospital of Gran Canaria Dr. Negrin, Canarian Health System, Las Palmas de Gran Canaria, Spain

Josep F Nomdedeu

15 Servei d´Hematologia Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, IIB Sant Pau/Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain

Laura Murillo-Sanjuán

16 Pediatric Hematology and Oncology Division, Hospital Universitari Vall d’Hebron, Vall d’Hebron Institut de Recerca, Barcelona, Spain

Cristina Díaz de Heredia

16 Pediatric Hematology and Oncology Division, Hospital Universitari Vall d’Hebron, Vall d’Hebron Institut de Recerca, Barcelona, Spain

Antonio Pérez-Martinez

17 Pediatric Department, Universidad Autonoma de Madrid, Madrid, Spain

Félix López-Cardenas

20 Instituto Biosanitario de Salamanca (IBSAL), Salamanca, Spain

Carolina Martínez-Laperche

22 Servicio de Hematología, Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain

Nieves Dorado-Herrero

22 Servicio de Hematología, Hospital General Universitario Gregorio Marañón. Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain

Francisco M Marco

23 Immunology Department, Dr. Balmis General University Hospital; Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain

Felipe Prósper

6 Centro de Investigación Biomédica en Red de Oncología (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain

Pablo Menendez

6 Centro de Investigación Biomédica en Red de Oncología (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain

David Valcárcel

28 Servei d’Hematologia, Vall d’Hebron Hospital Universitari; Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO); Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain

Esteban Ballestar

2 Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), Barcelona, Spain

Csaba Bödör

9 HCEMM-SE Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary

Anna Bigas

6 Centro de Investigación Biomédica en Red de Oncología (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain

Albert Catalá

3 Department of Hematology and Oncology, Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Déu, Barcelona, Spain

Marcin W Wlodarski

33 Department of Hematology, St. Jude Children’s Research Hospital, Memphis, TN, United States

Alessandra Giorgetti

1 Regenerative Medicine Program, Bellvitge Institute for Biomedical Research (IDIBELL) and Program for Clinical Translation of Regenerative Medicine in Catalonia (P-CMRC), Barcelona, Spain